These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22854298)

  • 1. Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling.
    Kojonazarov B; Sydykov A; Pullamsetti SS; Luitel H; Dahal BK; Kosanovic D; Tian X; Majewski M; Baumann C; Evans S; Phillips P; Fairman D; Davie N; Wayman C; Kilty I; Weissmann N; Grimminger F; Seeger W; Ghofrani HA; Schermuly RT
    Int J Cardiol; 2013 Sep; 167(6):2630-7. PubMed ID: 22854298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
    Leong ZP; Hikasa Y
    Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
    Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
    Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S
    Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early versus late cardiac remodeling during right ventricular pressure load and impact of preventive versus rescue therapy with endothelin-1 receptor blockers.
    Ramos SR; Pieles G; Sun M; Slorach C; Hui W; Friedberg MK
    J Appl Physiol (1985); 2018 May; 124(5):1349-1362. PubMed ID: 29446710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin Receptor-Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension.
    Sharifi Kia D; Benza E; Bachman TN; Tushak C; Kim K; Simon MA
    J Am Heart Assoc; 2020 Jul; 9(13):e015708. PubMed ID: 32552157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
    Wang YD; Li YD; Ding XY; Wu XP; Li C; Guo DC; Shi YP; Lu XZ
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):441-450. PubMed ID: 30350115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.
    de Raaf MA; Herrmann FE; Schalij I; de Man FS; Vonk-Noordegraaf A; Guignabert C; Wollin L; Bogaard HJ
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H604-12. PubMed ID: 27342880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats.
    Abe K; Toba M; Alzoubi A; Koubsky K; Ito M; Ota H; Gairhe S; Gerthoffer WT; Fagan KA; McMurtry IF; Oka M
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):804-8. PubMed ID: 21378262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.
    Dahal BK; Kosanovic D; Kaulen C; Cornitescu T; Savai R; Hoffmann J; Reiss I; Ghofrani HA; Weissmann N; Kuebler WM; Seeger W; Grimminger F; Schermuly RT
    Respir Res; 2011 May; 12(1):60. PubMed ID: 21535881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
    Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
    PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart Rate Reduction Improves Right Ventricular Function and Fibrosis in Pulmonary Hypertension.
    Ishii R; Okumura K; Akazawa Y; Malhi M; Ebata R; Sun M; Fujioka T; Kato H; Honjo O; Kabir G; Kuebler WM; Connelly K; Maynes JT; Friedberg MK
    Am J Respir Cell Mol Biol; 2020 Dec; 63(6):843-855. PubMed ID: 32915674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
    Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
    Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
    Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats.
    Bogaard HJ; Mizuno S; Hussaini AA; Toldo S; Abbate A; Kraskauskas D; Kasper M; Natarajan R; Voelkel NF
    Am J Respir Crit Care Med; 2011 May; 183(10):1402-10. PubMed ID: 21297075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
    Campos-Carraro C; Turck P; de Lima-Seolin BG; Tavares AMV; Dos Santos Lacerda D; Corssac GB; Teixeira RB; Hickmann A; Llesuy S; da Rosa Araujo AS; Belló-Klein A
    J Cardiovasc Pharmacol; 2018 Nov; 72(5):214-221. PubMed ID: 30212415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.